Evolution Wealth Advisors LLC Has $176,000 Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Evolution Wealth Advisors LLC cut its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 11.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,115 shares of the company’s stock after selling 1,385 shares during the quarter. Evolution Wealth Advisors LLC’s holdings in BlackRock Health Sciences Term Trust were worth $176,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Register Financial Advisors LLC boosted its position in shares of BlackRock Health Sciences Term Trust by 5,365.6% in the second quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after acquiring an additional 6,707 shares during the period. Shaker Financial Services LLC bought a new stake in BlackRock Health Sciences Term Trust in the 2nd quarter valued at about $184,000. Comerica Bank grew its position in shares of BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after purchasing an additional 3,671 shares in the last quarter. Dakota Wealth Management increased its holdings in shares of BlackRock Health Sciences Term Trust by 5.3% during the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock worth $280,000 after purchasing an additional 915 shares during the period. Finally, B. Riley Wealth Advisors Inc. bought a new position in shares of BlackRock Health Sciences Term Trust during the first quarter worth approximately $285,000.

Insider Transactions at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. purchased 29,795 shares of the business’s stock in a transaction dated Wednesday, October 16th. The stock was bought at an average price of 15.81 per share, with a total value of 471,058.95. Following the acquisition, the insider now owns 20,750,913 shares in the company, valued at approximately 328,071,934.53. The trade was a 0.14 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last three months, insiders have purchased 99,630 shares of company stock valued at $1,585,113.

BlackRock Health Sciences Term Trust Trading Down 2.1 %

Shares of BMEZ stock opened at 15.26 on Friday. BlackRock Health Sciences Term Trust has a 1 year low of 13.53 and a 1 year high of 16.59. The stock has a 50 day simple moving average of 15.78 and a 200 day simple moving average of 15.57.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.1769 per share. This represents a $2.12 annualized dividend and a dividend yield of 13.91%. The ex-dividend date is Friday, November 15th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.